QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   3.99 (+2.05%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.07 (+0.25%)
MU   111.93 (-3.78%)
GE   152.95 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.86 (-0.07%)
AMC   2.93 (-1.68%)
PFE   25.39 (-0.16%)
PYPL   62.10 (-1.83%)
XOM   118.46 (-0.14%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   3.99 (+2.05%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.07 (+0.25%)
MU   111.93 (-3.78%)
GE   152.95 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.86 (-0.07%)
AMC   2.93 (-1.68%)
PFE   25.39 (-0.16%)
PYPL   62.10 (-1.83%)
XOM   118.46 (-0.14%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   3.99 (+2.05%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.07 (+0.25%)
MU   111.93 (-3.78%)
GE   152.95 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.86 (-0.07%)
AMC   2.93 (-1.68%)
PFE   25.39 (-0.16%)
PYPL   62.10 (-1.83%)
XOM   118.46 (-0.14%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   3.99 (+2.05%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.07 (+0.25%)
MU   111.93 (-3.78%)
GE   152.95 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.86 (-0.07%)
AMC   2.93 (-1.68%)
PFE   25.39 (-0.16%)
PYPL   62.10 (-1.83%)
XOM   118.46 (-0.14%)
Free Trial

Compare Stocks

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
C$0.58
+1.8%		C$0.58
C$0.17
▼
C$0.85
C$87.32MN/A56,279 shs11,848 shs
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$0.36
+1.4%		C$0.38
C$0.23
▼
C$0.47
C$48.48M0.2872,244 shs5,500 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
0.00%0.00%0.00%0.00%0.00%
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
0.00%-2.78%-6.67%-15.66%-11.39%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
N/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
3.00
BuyN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
C$1.75M49.95C$0.08 per share7.16C$0.05 per share12.89
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$22.42M2.16C$0.09 per share4.13C$0.20 per share1.78

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
N/A-C$0.08N/A∞N/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$3.72MC$0.0311.83∞N/A16.57%14.66%1.87%5/9/2024 (Estimated)

Latest MBX, PIQ, IGX, and IXI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/14/2024Q1 2024
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AC$0.02+C$0.02C$0.02C$8.10 millionC$8.41 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
N/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
164.62
2.77
2.69
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
24.53
8.53
5.57

Ownership

Institutional Ownership

CompanyInstitutional Ownership
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
N/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
0.42%

Insider Ownership

CompanyInsider Ownership
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
N/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
14.07%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
IntelGenx Technologies Corp. stock logo
IGX
IntelGenx Technologies
48150.55 millionN/ANot Optionable
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/A136.55 millionN/ANot Optionable

MBX, PIQ, IGX, and IXI Headlines

SourceHeadline
Microbix Presenting at the 2024 Bloom Burton ConferenceMicrobix Presenting at the 2024 Bloom Burton Conference
finance.yahoo.com - April 11 at 9:13 AM
Microbix Announces Annual and Special Meeting Voting ResultsMicrobix Announces Annual and Special Meeting Voting Results
finance.yahoo.com - April 1 at 7:42 AM
Microbix’s Clot-Buster Drug Project AdvancesMicrobix’s Clot-Buster Drug Project Advances
finance.yahoo.com - March 14 at 8:22 AM
Bo Hollas Sells 100,000 Shares of Microbix Biosystems Inc. (TSE:MBX) StockBo Hollas Sells 100,000 Shares of Microbix Biosystems Inc. (TSE:MBX) Stock
insidertrades.com - March 12 at 5:23 AM
Microbix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck CancerMicrobix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck Cancer
finanznachrichten.de - March 11 at 3:10 PM
Stocks in play: Microbix Biosystems Inc.Stocks in play: Microbix Biosystems Inc.
ca.finance.yahoo.com - March 11 at 10:10 AM
Microbix Biosystems Inc.Microbix Biosystems Inc.
wsj.com - March 1 at 4:14 PM
Microbix Announces Issuance of Stock OptionsMicrobix Announces Issuance of Stock Options
finance.yahoo.com - February 26 at 10:35 AM
Microbix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)Microbix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)
finance.yahoo.com - February 17 at 8:26 AM
Microbix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024Microbix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024
finanznachrichten.de - February 14 at 2:04 PM
Microbix Reports Record Results for Q1 Fiscal 2024Microbix Reports Record Results for Q1 Fiscal 2024
finance.yahoo.com - February 14 at 8:57 AM
Microbix Schedules Release of Results for Q1 Fiscal 2024Microbix Schedules Release of Results for Q1 Fiscal 2024
finance.yahoo.com - February 7 at 11:29 AM
Microbix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease PathogenMicrobix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen
finanznachrichten.de - February 6 at 10:26 AM
Microbix Unveils Test Control for Gastric Ulcer Disease PathogenMicrobix Unveils Test Control for Gastric Ulcer Disease Pathogen
finance.yahoo.com - February 6 at 10:26 AM
Microbix Achieves Further QAPs Sales RecordMicrobix Achieves Further QAPs Sales Record
finance.yahoo.com - January 3 at 11:20 AM
Microbix Biosystems Full Year 2023 Earnings: Revenues Miss ExpectationsMicrobix Biosystems Full Year 2023 Earnings: Revenues Miss Expectations
finance.yahoo.com - December 22 at 10:06 AM
Microbix Reports Results for Q4 & Full-Year Fiscal 2023Microbix Reports Results for Q4 & Full-Year Fiscal 2023
finance.yahoo.com - December 21 at 8:11 AM
Microbix & Seegene USA Jointly Enhancing Lab Test AccuracyMicrobix & Seegene USA Jointly Enhancing Lab Test Accuracy
finance.yahoo.com - December 14 at 10:24 AM
Microbix & BioGX Collaborate on real-time PCR Assays & ControlsMicrobix & BioGX Collaborate on real-time PCR Assays & Controls
finance.yahoo.com - December 7 at 8:19 AM
Microbix Presenting at Florida Capital Event ConferenceMicrobix Presenting at Florida Capital Event Conference
financialpost.com - November 17 at 7:13 AM
Microbix Biosystems Inc.: Microbix Clot-Buster Drug Fully-Funded For Return to U.S. MarketMicrobix Biosystems Inc.: Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market
finanznachrichten.de - November 16 at 8:06 AM
Microbix Clot-Buster Drug Fully-Funded For Return to U.S. MarketMicrobix Clot-Buster Drug Fully-Funded For Return to U.S. Market
finance.yahoo.com - November 16 at 8:06 AM
Microbix & Ulisse Biomed Collaborate on HPV Controls & AssaysMicrobix & Ulisse Biomed Collaborate on HPV Controls & Assays
finance.yahoo.com - November 10 at 9:19 AM
Microbix QAPs Supporting HPV Testing in IrelandMicrobix QAPs Supporting HPV Testing in Ireland
finance.yahoo.com - October 27 at 8:16 AM

Media Sentiment Over Time

Company Descriptions

IntelGenx Technologies logo

IntelGenx Technologies

CVE:IGX
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Microbix Biosystems logo

Microbix Biosystems

TSE:MBX
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.